| Literature DB >> 31937867 |
Anna Sofia Simula1,2,3, Olli Ruokolainen4,5, Petteri Oura4,5, Mikko Lausmaa4,5, Riikka Holopainen6, Maija Paukkunen7, Juha Auvinen4,5,8, Steven J Linton9, Jonathan C Hill10, Jaro Karppinen4,5,11.
Abstract
The Short form of the Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ-short) and the STarT Back Tool (SBT) have been developed to screen for risk factors for future low back pain (LBP) -related disability and work loss respectively. The aim of this study was to investigate the accordance of the two questionnaires and to evaluate the accumulation of risk factors in the risk groups of both screening tools in a large population-based sample. The study population consisted of 3079 participants of the Northern Finland Birth Cohort 1966 who had reported LBP over the previous 12 months and had SBT and ÖMPSQ-short data. We evaluated the association of depressive and anxiety symptoms (Hopkins symptom check list-25, Generalized anxiety disorder 7 questionnaire, and Beck's Depression Inventory 21), psychological features (Fear-Avoidance Beliefs Questionnaire), lifestyle characteristics (BMI, smoking, alcohol abuse, physical inactivity) and social factors (education level) with the SBT and ÖMPSQ-short risk groups. The high-risk groups of both questionnaires were associated (p < 0.001) with depressive and anxiety symptoms and fear-avoidance beliefs. In addition, adverse lifestyle factors accumulated in the higher risk groups, especially from the ÖMPSQ-short. Agreement between the two questionnaires was moderate for men and fair for women.Entities:
Mesh:
Year: 2020 PMID: 31937867 PMCID: PMC6959304 DOI: 10.1038/s41598-019-57105-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of study population.
| men | women | missing men/women n | |
|---|---|---|---|
| Gender distribution % (n) | 43 (1331) | 57 (1748) | |
| SBT total score median (IQR) | 1 (1–2) | 1 (1–2) | 0/0 |
| ÖMPSQ-short total score median (IQR) | 23 (15–33) | 26 (17–37) | 0/0 |
| HSCL-25 median (IQR) | 1.24 (1.12–1.48) | 1.32 (1.16–1.56) | 135/176 |
| HSCL-25 ≥ 1.55% (n) | 19.6 (235) | 26.1 (410) | |
| GAD-7 + median (IQR) | 1 (0–4) | 2 (0–5) | 150/142 |
| GAD-7 ≥ 10% (n) | 2.0 (24) | 3.7 (60) | |
| BDI-21 median (IQR) | 4 (1–8) | 5 (2–10) | 61/72 |
| BDI-21 ≥ 14% (n) | 8.9 (113) | 13.5 (227) | |
| FABQ-P median (IQR) | 10 (5–14) | 9 (5–14) | 19/14 |
| Low risk % (n) | 73.1 (959) | 74.9 (1298) | |
| Medium risk % (n) | 8.8 (116) | 8.7 (150) | |
| High risk % (n) | 18.1 (237) | 16.5 (286) | |
| FABQ-W median (IQR) | 9 (2–18) | 7 (0–16) | 31/54 |
| Low risk % (n) | 79.1 (1028) | 81.7 (1384) | |
| Medium risk % (n) | 9.3 (121) | 8.1 (138) | |
| High risk % (n) | 11.6 (151) | 10.2 (172) | |
| BMI mean (SD) | 27.5 (4.3) | 26.8 (5.5) | 2/3 |
| <25% (n) | 27.8 (369) | 44.1 (770) | |
| 25–29.99% (n) | 49.1 (653) | 32.9 (574) | |
| ≥30% (n) | 23.1 (307) | 23.0 (401) | |
| Smoking % (n) | 93/85 | ||
| non-smokers | 46 (571) | 56 (937) | |
| former smokers | 34 (424) | 26 (435) | |
| current smokers | 20 (243) | 18 (291) | |
| Alcohol abuse % (n) | 8.6 (108) | 8.5(143) | 77/66 |
| Physical activity % (n) | 100/81 | ||
| Inactive (less than once a week) | 33 (402) | 25 (421) | |
| Active (once a week or more often) | 62 (829) | 71 (1246) | |
| Education % (n) | 134/130 | ||
| under 9 years | 3 (38) | 3 (48) | |
| 9–12 years | 73 (868) | 67 (1078) | |
| over 12 years | 24 (291) | 30 (492) | |
| Working status % (n) | 290/298 | ||
| unemployed | 5 (54) | 4 (56) | |
| working full-time or part-time | 90 (940) | 89 (1283) | |
| others | 5 (47) | 8 (111) |
ÖMPSQ-short (Örebro Musculoskeletal Pain Screening Questionnaire short form), SBT (Start Back Tool), IQR (interquartile range), HSCL-25 (Hopkins symptom check list-25), GAD-7 (Generalized anxiety disorder 7 questionnaire), BDI-21 (Beck’s Depression Inventory 21), FABQ-P (Fear avoidance beliefs questionnaire physical activity subscale), FABQ-W (Fear-avoidance beliefs questionnaire work subscale), BMI (body mass index).
Single question medians of ÖMPSQ-short questions and distribution of study participants in the risk groups.
| ÖMPSQ-short | Men (n = 1331) median (IQR) | Women (n = 1748) median (IQR) | p-value for gender difference |
|---|---|---|---|
| 1. How long have you had your current pain problem? Tick (√) one. | 3 (1–10) | 4 (1–10) | 0.190 |
| 2. How would you rate the pain that you have had during the past week? Circle one. | 3 (2–4) | 3 (2–5) | |
| 3. I can do light work (or home duties) for an hour. | 0 (0–1) | 0 (0–1) | 0.545 |
| 4. I can sleep at night. | 0 (0–2) | 1 (0–3) | |
| 5. How tense or anxious have you felt in the past week? Circle one. | 2 (1–4) | 3 (1–5) | |
| 6. How much have you been bothered by feeling depressed in the past week? Circle one. | 0 (0–2) | 1 (0–2) | |
| 7. In your view, how large is the risk that your current pain may become persistent? | 3 (1–6) | 4 (1–7) | |
| 8. In your estimation, what are the chances you will be working your normal duties (at home or work) in 3 months? | 0 (0–1) | 0 (0–1) | 0.090 |
| 9. An increase in pain is an indication that I should stop what I’m doing until the pain decreases. | 6 (2–9) | 6 (2–8) | 0.346 |
| 10. I should not do my normal work (at work or home duties) with my present pain. | 0 (0–2) | 0 (0–2) | 0.853 |
| Risk group % (n) | |||
| low | 85.1 (1133) | 80.1 (1400) | |
| medium | 8.4 (112) | 11.3 (198) | |
| high | 6.5 (86) | 8.6 (150) |
For all 10 questions, a higher number indicates a greater impairment. Gender differences were tested using the Mann-Whitney U test for the ÖMPSQ-short individual questions and the Chi-square test for the risk groups. ÖMPSQ (Örebro Musculoskeletal Pain Screening Questionnaire).
Percentages of ‘agree’ responses to SBT Questions 1–8 and percentages of two highest response options for Question 9, and the distribution of study participants in the risk groups.
| SBT | Men (n = 1331) % (n) | Women (n = 1748) % (n) | p-value for gender difference |
|---|---|---|---|
| 1. Has your back pain spread down your leg(s) at some time in the last 2 weeks? | 29 (382) | 32 (560) | |
| 2. Have you had pain in the shoulder or neck at some time in the last 2 weeks? | 61 (810) | 74 (1291) | |
| 3. Have you only walked short distances because of your back pain? | 5 (62) | 6 (109) | 0.058 |
| 4. In the last 2 weeks, have you dressed more slowly than usual because of back pain? | 11 (149) | 10 (166) | 0.124 |
| 5. Do you think it’s not really safe for a person with a condition like yours to be physically active? | 5 (70) | 5 (80) | 0.383 |
| 6. Have worrying thoughts been going through your mind a lot of the time? | 19 (255) | 21 (373) | 0.137 |
| 7. Do you feel that your back pain is terrible and it’s never going to get any better? | 10 (135) | 7 (116) | |
| 8. In general have you stopped enjoying all the things you usually enjoy? | 21 (285) | 20 (347) | 0.288 |
| 9. Overall, how bothersome has your back pain been in the last 2 weeks? | 7 (92) | 8 (132) | 0.499 |
| Risk group % (n) | 0.600 | ||
| low | 86.2 (1147) | 87.4 (1527) | |
| medium | 10.1 (134) | 9.4 (164) | |
| high | 3.8 (50) | 3.3 (57) | 0.457 |
Gender differences were tested using the Chi-square test. SBT (Start Back Tool, IQR (interquartile range), Q1–10 (Question 1–10).
Figure 1Sankey plots representing the accordance of the SBT (Start Back Tool) and ÖMPSQ-short (Örebro Musculoskeletal Pain Screening Questionnaire) risk groups among men.
Figure 2Sankey plots representing the accordance of the SBT (Start Back Tool) and ÖMPSQ-short (Örebro Musculoskeletal Pain Screening Questionnaire) risk groups among women.
Association between SBT or ÖMPSQ-short risk groups and psychiatric and psychological characteristics, analysed using the Chi-square test.
| SBT % (n) | ÖMPSQ-short % (n) | |||||||
|---|---|---|---|---|---|---|---|---|
| Low-risk | Medium-risk | High-risk | P value | Low-risk | Medium- risk | High-risk | P value | |
| HSCL-25 ≥ 1.55 | 16 (167) | 40.7 (48) | 51.3 (20) | <0.001 | 15.2 (156) | 36.4 (36) | 58.1 (43) | <0.001 |
| GAD-7 ≥ 10 | 1.1 (11) | 5.9 (7) | 14.3 (6) | <0.001 | 0.9 (9) | 3.2 (3) | 15.6 (12) | <0.001 |
| BDI-21 ≥ 14 | 6.2 (68) | 22.2 (28) | 36.2 (17) | <0.001 | 5.2 (57) | 19.2 (20) | 45.0 (36) | <0.001 |
| FABQ-P | <0.001 | <0.001 | ||||||
| Low risk | 77.1 (871) | 55.6 (74) | 28 (14) | 78.1 (871) | 51.8 (58) | 35.3 (30) | ||
| Medium risk | 8.3 (94) | 14.3 (19) | 6.0 (3) | 8.2 (91) | 14.3 (16) | 10.6 (9) | ||
| High risk | 14.5 (164) | 30.1 (40) | 66.0 (33) | 13.7 (153) | 33.9 (38) | 54.1 (46) | ||
| FABQ-W | <0.001 | <0.001 | ||||||
| Low risk | 83.3 (935) | 56.6 (73) | 41.7 (20) | 85.0 (943) | 54.1 (59) | 32.1 (26) | ||
| Medium risk | 7.8 (88) | 22.5 (29) | 8.3 (4) | 7.1 (79) | 23.9 (26) | 19.8 (16) | ||
| High risk | 8.9 (100) | 20.9 (27) | 50.0 (24) | 7.9 (88) | 22.0 (24) | 48.1 (39) | ||
| HSCL-25 ≥ 1.55 | 23.3 (322) | 40.7 (60) | 51.3 (28) | <0.001 | 19.7 (249) | 43.3 (77) | 66.1 (84) | <0.001 |
| GAD-7 ≥ 10 | 2.5 (35) | 11.4 (17) | 15.1 (8) | <0.001 | 1.6 (21) | 8.4 (15) | 18.3 (24) | <0.001 |
| BDI-21 ≥ 14 | 9.9 (145) | 35.5 (55) | 50.9 (27) | <0.001 | 7.9 (107) | 22.5 (41) | 54.5 (79) | <0.001 |
| FABQ-P | <0.001 | <0.001 | ||||||
| Low risk | 78.8 (1194) | 53.1 (86) | 32.1 (18) | 79.9 (1110) | 59.6 (118) | 47.6 (70) | ||
| Medium risk | 7.9 (120) | 13.6 (22) | 14.3 (8) | 7.7 (107) | 13.1 (26) | 11.6 (17) | ||
| High risk | 13.3 (202) | 33.3 (54) | 53.6 (33) | 13.7 (172) | 27.3 (54) | 40.8 (60) | ||
| FABQ-W | <0.001 | <0.001 | ||||||
| Low risk | 84.8 (1258) | 67.1 (104) | 39.3 (22) | 87.5 (1190) | 65.8 (127) | 47.5 (67) | ||
| Medium risk | 7.4 (110) | 13.5 (21) | 12.5 (7) | 6.7 (91) | 15.0 (29) | 12.8 (18) | ||
| High risk | 7.8 (115) | 19.3 (30) | 48.2 (27) | 5.8 (79) | 19.2 (37) | 39.7 (56) | ||
ÖMPSQ (Örebro Musculoskeletal Pain Screening Questionnaire), SBT (Start Back Tool), HSCL-25 (Hopkins symptom check list-25), GAD-7 (Generalized anxiety disorder 7 questionnaire), BDI-21 (Beck’s Depression Inventory), FABQ-P (Fear-avoidance beliefs questionnaire physical activity subscale), FABQ-W (Fear-avoidance beliefs questionnaire work subscale).
Association between SBT or ÖMPSQ-short risk groups and lifestyle and social characteristics, analysed using the Chi-square test.
| SBT % (n) | P value | ÖMPSQ-short % (n) | P value | |||||
|---|---|---|---|---|---|---|---|---|
| Low-risk | Medium-risk | High-risk | Low-risk | Medium-risk | High-risk | |||
| BMI | ||||||||
| <25 | 28.3 (324) | 24.8 (33) | 24.0 (12) | 28.3 (320) | 23.2 (26) | 26.7 (23) | ||
| 25–29.99 | 50.1 (574) | 45.9 (61) | 36.0 (18) | 50.2 (568) | 42.0 (47) | 44.2 (38) | ||
| ≥30 | 21.6 (248) | 29.3 (39) | 40.0 (20) | 21.5 (243) | 34.8 (39) | 29.1 (25) | ||
| Smoking | 16.8 (181) | 37.2 (45) | 41.5 (17) | 17.0 (179) | 28.0 (30) | 45.3 (34) | ||
| Alcohol abuse | 7.9 (86) | 11.4 (14) | 18.2 (8) | 7.6 (81) | 12.1 (13) | 17.7 (14) | ||
| Physically inactive | 31.4 (336) | 39.8 (47) | 43.1 (19) | 0.058 | 31.3 (328) | 32.1 (34) | 52.6 (40) | |
| Education years | ||||||||
| <9 | 2.5 (26) | 9.0 (10) | 5.0 (2) | 2.7 (28) | 4.0 (4) | 8.0 (6) | ||
| 9–12 | 71.7 (747) | 76.5 (88) | 82.5 (33) | 71.2 (728) | 80.0 (80) | 80.0 (60) | ||
| >12 | 25.8 (269) | 14.8 (17) | 12.5 (5) | 26.0 (266) | 16.0 (16) | 12.0 (9) | ||
| BMI | ||||||||
| <25 | 45.9 (699) | 32.9 (54) | 29.8 (17) | 46.6 (651) | 36.9 (55) | 32.3 (64) | ||
| 25–29.99 | 32.9 (502) | 32.9 (54) | 31.6 (18) | 32.3 (452) | 29.5 (44) | 39.4 (78) | ||
| ≥30 | 21.3 (323) | 34.1 (56) | 38.6 (22) | 21.2 (295) | 33.6 (50) | 28.3 (56) | ||
| Smoking | 16.2 (236) | 26.5 (40) | 27.3 (15) | 15.5 (207) | 27.9 (39) | 24.2 (45) | ||
| Alcohol abuse | 8.0 (118) | 12.3 (19) | 10.9 (6) | 0.150 | 7.9 (106) | 17.6 (25) | 6.3 (12) | |
| Physically Inactive | 23.4 (342) | 35.9 (55) | 43.6 (24) | 22.9 (307) | 45 (63) | 27.0 (51) | ||
| Education years | ||||||||
| <9 | 2.3 (33) | 6.8 (10) | 9.3 (5) | 2.3 (30) | 8.2 (11) | 3.8 (7) | ||
| 9–12 | 66.0 (936) | 71.9 (105) | 68.5 (37) | 65.0 (844) | 70.1 (94) | 75.7 (140) | ||
| >12 | 31.7 (449) | 21.2 (31) | 22.2 (12) | 32.7 (425) | 21.6 (29) | 20.5 (38) | ||
ÖMPSQ (Örebro Musculoskeletal Pain Screening Questionnaire), SBT (Start Back Screening Tool), BMI (body mass index).